Inactief instrument

Andere talen Immunomedics, Inc.

Aandelen

IMMU

US4529071080

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves	27-03-23
Everest Medicines Limited announced that it has received $280 million in funding from Immunomedics, Inc.	27-03-23
Gilead to Acquire Remaining Worldwide Rights of Trodelvy	16-08-22
Protara Therapeutics : Announces Appointment of Martin Sebastian Olivo, M.D. as Chief Medical Officer	20-04-21
La banque d'affaires Lazard a vu bondir son bénéfice net en 2020	05-02-21
Gilead Sciences : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020	11-01-21
Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer	11-12-20
Gilead Sciences : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany	10-12-20
Gilead Sciences : Announces Third Quarter 2020 Financial Results	29-10-20
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales -- Update	29-10-20
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales	28-10-20
Gilead Sciences : Completes Acquisition of Immunomedics, Inc.	26-10-20
IMMUNOMEDICS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-10-20
Immunomedics, Inc. Announces Board Changes	23-10-20
BB Biotech sombre dans le rouge au 3e trimestre, reste à flot sur 9 mois	23-10-20
HBM im Halbjahr 2020/21 mit Gewinnsprung - Zuversichtlich ins zweite Halbjahr	23-10-20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Biotechnology Select Industry Index	23-10-20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Global BMI Index	23-10-20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P TMI Index	23-10-20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Index	23-10-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Immunomedics, Inc.

Aandelen

IMMU

US4529071080

Andere talen

Filters